Table 2.

“Dose of Hope” measures.

Variables
Baseline
	Sociodemographics:	Gender, age, educational attainment, marital and sexual orientation status, employment and housing status, income level, health care utilization and insurance status	Behavioral/community characteristics/indicators (TRA and DOI) [30-35,40] Faith and place of worship affiliation, community affiliations, group memberships, mono and polymorphic network opinion leadership, network linkages, volunteerism experience, previous clinical trial experiences and knowledge, recent volunteer health behaviors (eg, organ donation in past 12 months), health research and clinical trial attitudes, social support indicators (eg, RAND social health battery) and personal network interactions, trust in provider, health research organization, and clinical research involvement scales (measured by CRIS)
Follow-up (3- and 6-month)
	Sociodemographics:	Employment and housing status, health care utilization, and insurance status (3-month recall)	Behavioral/community characteristics/indicators (TRA and DOI) [30-39] Health and clinical trial information and media consumption, modes of network communication, community affiliations and group memberships, network linkages, opinion leadership, clinical trial interest and knowledge, Emory clinical research experience, recent volunteer health behaviors (eg, organ donation in past 3 months), health research and clinical trial attitudes, perceived social support for clinical research involvement (personal network support), social activism congruence, trust in provider scale (measured by CRIS)
Clinical trial variables (24-months post baseline)			Clinical trial variables (tracking screening and enrollment database) Date of clinical trial site contact, date of screening, date of enrollment, reasons for study exclusions, recruitment source/venue